Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914475-24-000218
Filing Date
2024-11-07
Accepted
2024-11-07 19:42:38
Documents
1
Period of Report
2024-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1731026551.html 4  
1 FORM 4 wk-form4_1731026551.xml 4 3259
  Complete submission text file 0000914475-24-000218.txt   4755
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Issuer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 000-22705 | Film No.: 241437616